IBDEI09A ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12345,1,4,0)
 ;;=4^428.40
 ;;^UTILITY(U,$J,358.3,12345,1,5,0)
 ;;=5^Heart Failure, Diastolic& Systolic
 ;;^UTILITY(U,$J,358.3,12345,2)
 ;;=Heart Failure, Systolic and Diastolic^328596
 ;;^UTILITY(U,$J,358.3,12346,0)
 ;;=428.41^^80^691^40
 ;;^UTILITY(U,$J,358.3,12346,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12346,1,4,0)
 ;;=4^428.41
 ;;^UTILITY(U,$J,358.3,12346,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute
 ;;^UTILITY(U,$J,358.3,12346,2)
 ;;=Heart Failure, Systolic & Diastolic, Acute^328500
 ;;^UTILITY(U,$J,358.3,12347,0)
 ;;=428.42^^80^691^42
 ;;^UTILITY(U,$J,358.3,12347,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12347,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,12347,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Chronic
 ;;^UTILITY(U,$J,358.3,12347,2)
 ;;= Heart Failure, Systolic & Diastolic, Chronic^328501
 ;;^UTILITY(U,$J,358.3,12348,0)
 ;;=428.43^^80^691^41
 ;;^UTILITY(U,$J,358.3,12348,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12348,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,12348,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute On Chronic
 ;;^UTILITY(U,$J,358.3,12348,2)
 ;;= Heart Failure, Systolic & Diastolic, Acute on Chronic^328502
 ;;^UTILITY(U,$J,358.3,12349,0)
 ;;=396.3^^80^691^7
 ;;^UTILITY(U,$J,358.3,12349,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12349,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,12349,1,5,0)
 ;;=5^Aortic And Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,12349,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,12350,0)
 ;;=414.3^^80^691^17
 ;;^UTILITY(U,$J,358.3,12350,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12350,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,12350,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,12350,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,12351,0)
 ;;=453.9^^80^691^82
 ;;^UTILITY(U,$J,358.3,12351,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12351,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,12351,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,12351,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,12352,0)
 ;;=453.89^^80^691^1
 ;;^UTILITY(U,$J,358.3,12352,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12352,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,12352,1,5,0)
 ;;=5^AC Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,12352,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,12353,0)
 ;;=453.79^^80^691^27
 ;;^UTILITY(U,$J,358.3,12353,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12353,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,12353,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,12353,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,12354,0)
 ;;=425.11^^80^691^58
 ;;^UTILITY(U,$J,358.3,12354,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12354,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,12354,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,12354,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,12355,0)
 ;;=425.18^^80^691^63
 ;;^UTILITY(U,$J,358.3,12355,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12355,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,12355,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,12355,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,12356,0)
 ;;=V12.55^^80^691^53
 ;;^UTILITY(U,$J,358.3,12356,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12356,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,12356,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,12356,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,12357,0)
 ;;=414.4^^80^691^16
 ;;^UTILITY(U,$J,358.3,12357,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12357,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,12357,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,12357,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,12358,0)
 ;;=271.3^^80^692^17
 ;;^UTILITY(U,$J,358.3,12358,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12358,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,12358,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,12358,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,12359,0)
 ;;=611.1^^80^692^22
 ;;^UTILITY(U,$J,358.3,12359,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12359,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,12359,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,12359,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,12360,0)
 ;;=704.1^^80^692^23
 ;;^UTILITY(U,$J,358.3,12360,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12360,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,12360,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,12360,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,12361,0)
 ;;=251.2^^80^692^36
 ;;^UTILITY(U,$J,358.3,12361,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12361,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,12361,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,12361,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,12362,0)
 ;;=257.2^^80^692^37
 ;;^UTILITY(U,$J,358.3,12362,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12362,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,12362,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,12362,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,12363,0)
 ;;=253.2^^80^692^41
 ;;^UTILITY(U,$J,358.3,12363,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12363,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,12363,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,12363,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,12364,0)
 ;;=733.00^^80^692^52
 ;;^UTILITY(U,$J,358.3,12364,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12364,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,12364,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,12364,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,12365,0)
 ;;=278.00^^80^692^48
 ;;^UTILITY(U,$J,358.3,12365,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12365,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,12365,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,12365,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,12366,0)
 ;;=278.01^^80^692^47
 ;;^UTILITY(U,$J,358.3,12366,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12366,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,12366,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,12366,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,12367,0)
 ;;=250.80^^80^692^15
 ;;^UTILITY(U,$J,358.3,12367,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12367,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,12367,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,12367,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,12368,0)
 ;;=250.00^^80^692^9
 ;;^UTILITY(U,$J,358.3,12368,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12368,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,12368,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,12368,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,12369,0)
 ;;=250.40^^80^692^11
 ;;^UTILITY(U,$J,358.3,12369,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12369,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,12369,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,12369,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,12370,0)
 ;;=250.50^^80^692^14
 ;;^UTILITY(U,$J,358.3,12370,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12370,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,12370,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,12370,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,12371,0)
 ;;=250.60^^80^692^12
 ;;^UTILITY(U,$J,358.3,12371,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12371,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,12371,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,12371,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,12372,0)
 ;;=250.70^^80^692^13
 ;;^UTILITY(U,$J,358.3,12372,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12372,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,12372,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,12372,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,12373,0)
 ;;=250.01^^80^692^8
 ;;^UTILITY(U,$J,358.3,12373,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12373,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,12373,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,12373,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,12374,0)
 ;;=272.0^^80^692^28
 ;;^UTILITY(U,$J,358.3,12374,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12374,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,12374,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,12374,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,12375,0)
 ;;=272.1^^80^692^33
 ;;^UTILITY(U,$J,358.3,12375,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12375,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,12375,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,12375,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,12376,0)
 ;;=272.2^^80^692^30
 ;;^UTILITY(U,$J,358.3,12376,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12376,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,12376,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,12376,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,12377,0)
 ;;=275.42^^80^692^27
 ;;^UTILITY(U,$J,358.3,12377,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12377,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,12377,1,5,0)
 ;;=5^Hypercalcaemia
 ;;^UTILITY(U,$J,358.3,12377,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,12378,0)
 ;;=275.41^^80^692^35
 ;;^UTILITY(U,$J,358.3,12378,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12378,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,12378,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,12378,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,12379,0)
 ;;=276.7^^80^692^29
 ;;^UTILITY(U,$J,358.3,12379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12379,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,12379,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,12379,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,12380,0)
 ;;=275.2^^80^692^25
 ;;^UTILITY(U,$J,358.3,12380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,12380,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,12380,1,5,0)
 ;;=5^Hyper or Hypomagnesaemia
 ;;^UTILITY(U,$J,358.3,12380,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,12381,0)
 ;;=276.0^^80^692^31
 ;;^UTILITY(U,$J,358.3,12381,1,0)
 ;;=^358.31IA^5^2
